1. The difference between medicine and magic is that magicians know what they are doing

   • Rodney J. Hicks

   Editorial Commentary 16 October 2014 Pages: 1 - 4

2. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

   • Lisa Bodei
   • Mark Kidd
   • Irvin M. Modlin

   Original Article 02 October 2014 Pages: 5 - 19

   

3. ⁶⁸Ga-DOTA⁰-Tyr³-octreotide positron emission tomography in nasopharyngeal carcinoma

   • Volker H. Schartinger
   • József Dudás
   • Christian Uprimny

   Short Communication 17 September 2014 Pages: 20 - 24

   

4. Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside

   • Jeremy Lewin
   • Carleen Cullinane
   • Rodney J. Hicks

   Original Article 16 August 2014 Pages: 25 - 32

   

5. ⁶⁸Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to ¹²³I-MIBG SPECT/CT

   • Alexander Kroiss
   • Barry Lynn Shulkin
   • Irene Johanna Virgolini

   Original Article 19 August 2014 Pages: 33 - 41

   

6. Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology

   • Philipp Heusch
   • Felix Nensa
   • Christian Buchbender

   Original Article 12 August 2014 Pages: 42 - 48

   

7. Non-small-cell lung cancer resectability: diagnostic value of PET/MR

   • Francesco Fraioli
   • Nicholas J. Screaton
   • Ashley M. Groves

   Original Article Open access 15 August 2014 Pages: 49 - 55

   

8. [¹⁸F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results

   • Karsten Beiderwellen
   • Johannes Grueneisen
   • Lale Umutlu

   Original Article 16 September 2014 Pages: 56 - 65

   

9. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUV_max) guide us in the timing of colonoscopy?

   • F. B. van Hoeij
   • R. G. M. Keijsers
   • B. L. A. M. Weusten

   Original Article 20 August 2014 Pages: 66 - 71

   

10. Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment

    • Philippe Robin
    • Ronan Abgral
    • Pierre-Yves Salaun

    Original Article 29 August 2014 Pages: 72 - 78

    

11. ¹⁷⁷Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study

    • Krishan Kant Agarwal
    • Suhas Singla
    • Chandrasekhar Bal

    Original Article 29 July 2014 Pages: 79 - 88

    

12. Ethnic comparison of pharmacokinetics of ¹⁸F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects

    • Michio Senda
    • Masahiro Sasaki
    • Osama Sabri

    Original Article Open access 21 August 2014 Pages: 89 - 96

    

13. Reduced retention of Pittsburgh compound B in white matter lesions

    • Lidia Glodzik
    • Henry Rusinek
    • Mony de Leon

    Short Communication 21 October 2014 Pages: 97 - 102

    

14. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

    • Francesco Cicone
    • Giuseppe Minniti
    • Francesco Scopinaro

    Original Article 15 August 2014 Pages: 103 - 111

    

15. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [¹²³I]FP-CIT SPECT

    • I. Huertas-Fernández
    • F. J. García-Gómez
    • P. Mir

    Original Article 14 August 2014 Pages: 112 - 119

    

16. Test–retest reliability of ¹¹C-ORM-13070 in PET imaging of α_2C-adrenoceptors in vivo in the human brain

    • Jussi Lehto
    • Jere R. Virta
    • Juha O. Rinne

    Original Article 09 September 2014 Pages: 120 - 127

    

17. Preclinical evaluation and test–retest studies of [¹⁸F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu₅)

    • Selena Milicevic Sephton
    • Adrienne Müller Herde
    • Simon M. Ametamey

    Original Article 20 August 2014 Pages: 128 - 137

    

18. Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [¹⁸F]PBR102 and [¹⁸F]PBR111 in a model of excitotoxin-induced neuroinflammation

    • P. D. Callaghan
    • C. A. Wimberley
    • A. Katsifis

    Original Article 18 September 2014 Pages: 138 - 151

    

19. Diagnostic accuracy and impact on management of ¹⁸F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review

    • Anna Margherita Maffione
    • Egesta Lopci
    • Domenico Rubello

    Review Article 16 October 2014 Pages: 152 - 163

    

20. Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship

    • Eric Laffon
    • Henri de Clermont
    • Roger Marthan

    Letter to the Editor 22 October 2014 Pages: 164 - 165

    

21. Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship

    • Agostino Chiaravalloti
    • Orazio Schillaci

    Letter to the Editor 22 October 2014 Pages: 166 - 166

    

22. Athanasios D. Gouliamos, John A. Andreou and Paris A. Kosmidis (Eds): Imaging in Clinical Oncology

    • Nicola Frega
    • Luigi Mansi

    Book Review 09 August 2014 Pages: 167 - 168

23. Cristina Nanni, Stefano Fanti and Lucia Zanoni (eds): Radiology for PET/CT Reporting

    • Sara M. d. A. Giorgio
    • Luigi Mansi

    Book Review 31 July 2014 Pages: 169 - 169

24. In vivo visualization of prostate-specific membrane antigen in glioblastoma

    • Johannes Schwenck
    • Ghazaleh Tabatabai
    • Christian la Fougère

    Image of the Month 08 October 2014 Pages: 170 - 171